Department of Endocrinology, Beijing Ji Shui Tan Hospital, the 4th Medical College of Peking University, Xi Chen Qu Xin Jie Kou Dong Jie 31, 100035 Beijing, China.
J Endocrinol Invest. 2009 Oct;32(9):731-8. doi: 10.1007/BF03346528.
The prognosis of patients with metastasized thyroid carcinoma is not optimistic, necessitating the search for new treatment options.
Beneficial effects of retinoic acid (RA) have been suggested in thyroid cancer differentiation and the present study was performed to investigate the anti-metastatic potential of RA in respect of important determinants of metastatic behavior in thyroid carcinoma, focusing on the role of invasion-associated proteins.
Differentiated thyroid carcinoma cell lines FTC- 133 and XTC.UC1, and anaplastic thyroid cancer cell lines C643 and HTH74 were studied. All cell lines were cultured with alltrans- RA (ATRA) or the solvent ethanol. Invasion and adhesion potency in vitro was studied by transwell experiment and short-term adhesion assay. The involvement of invasion-associated proteins, urokinase type plasminogen activator (uPA), uPA receptor (uPAR), matrix metalloproteinase-2 (MMP-2) and E-cadherin, were investigated by semi-quantitative RT-PCR and Western blot.
In vitro invasion assay revealed that ATRA treatment could reduce the invasive potency in all the thyroid cancer cell lines, with the most significant effect in anaplastic cancer cells. Short-term adhesion assay suggested that ATRA increases cancer cell adhesion to extracellular matrix (ECM) in C643, HTH74 and XTC.UC1, probably through a transcriptional and translational regulation of some attachment molecules. RT-PCR andWestern blot both revealed diminished expression of uPAR in all four carcinoma cell lines. In C643 and HTH74 cell lines, the expression of uPA was reduced and the expression of E-cadherin was increased, whereas the MMP-2 expression was not significantly down-regulated in ATRA-treated group. In ATRA-treated FTC-133 and XTC.UC1 cell lines, MMP-2 expression was decreased, but no significant changes in uPA and E-cadherin expression were observed.
The present study demonstrates the influence of ATRA on both important determinants of metastatic behavior ("de-adhesion" and proteolysis) in thyroid carcinoma cell lines, especially in anaplastic cancer cells. These findings may add to the explanations for beneficial effects of RA in the treatment of metastatic thyroid carcinomas.
转移性甲状腺癌患者的预后不容乐观,因此需要寻找新的治疗方法。
已有研究表明维 A 酸(RA)对甲状腺癌的分化具有有益作用,本研究旨在探讨 RA 在甲状腺癌细胞重要转移行为决定因素方面的抗转移潜力,重点关注侵袭相关蛋白的作用。
研究了分化型甲状腺癌细胞系 FTC-133 和 XTC.UC1,以及间变性甲状腺癌细胞系 C643 和 HTH74。所有细胞系均用全反式 RA(ATRA)或溶剂乙醇培养。通过 Transwell 实验和短期粘附实验研究体外侵袭和粘附能力。通过半定量 RT-PCR 和 Western blot 研究侵袭相关蛋白尿激酶型纤溶酶原激活物(uPA)、uPA 受体(uPAR)、基质金属蛋白酶-2(MMP-2)和 E-钙粘蛋白的参与情况。
体外侵袭实验表明,ATRA 处理可降低所有甲状腺癌细胞系的侵袭能力,在间变性癌细胞中效果最为显著。短期粘附实验表明,ATRA 可能通过一些附着分子的转录和翻译调节,增加 C643、HTH74 和 XTC.UC1 癌细胞对细胞外基质(ECM)的粘附。RT-PCR 和 Western blot 均显示在所有四种癌细胞系中 uPAR 的表达均降低。在 C643 和 HTH74 细胞系中,uPA 的表达减少,E-钙粘蛋白的表达增加,而 ATRA 处理组 MMP-2 的表达无明显下调。在 ATRA 处理的 FTC-133 和 XTC.UC1 细胞系中,MMP-2 的表达降低,但 uPA 和 E-钙粘蛋白的表达无明显变化。
本研究表明 ATRA 对甲状腺癌细胞系中重要转移行为决定因素(“去粘附”和蛋白水解)均有影响,特别是在间变性癌细胞中。这些发现可能有助于解释 RA 在治疗转移性甲状腺癌中的有益作用。